GSK Investigational Site
Guarda 6300-035
0 studies enrolling now · 1 studies all time
What they study most
Asthma
Studies at this site
A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype
— Completed